Stem cell therapy delivery: treading the regulatory tightrope.

Abstract:

:The concept of stem cell therapy has engaged the attention of the public and scientists alike. Intensive research effort is focused upon understanding the biology and therapeutic potential of embryonic and adult stem cells, with the eventual goal of treating such pathologies as Parkinson's disease, diabetes, neurological injury and degenerations and cancer. Ex vivo expansion and transplantation of limbal epithelial stem cells to the corneas to treat blinding ocular surface disease was one of the first stem cell therapies to successfully reach the clinic. However, limbal epithelial stem cell research and therapy delivery has remained largely within the noncommercial academic clinician-scientist environment from which it was originally pioneered. In our experience, gaining regulatory approval has been as great a hurdle as surmounting the scientific challenges of stem cell therapy. Based upon our model of delivering 'accredited' limbal epithelial stem cell therapy to patients in compliance with Good Manufacturing Practice and the new European Union Tissues and Cells Directive, we address the key regulatory questions. This may help colleagues who are developing innovative academic research-driven stem cell therapies regarding donor consent, raw materials, quality assurance, laboratory specification, indemnity and funding.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Daniels JT,Secker GA,Shortt AJ,Tuft SJ,Seetharaman S

doi

10.2217/17460751.1.5.715

subject

Has Abstract

pub_date

2006-09-01 00:00:00

pages

715-9

issue

5

eissn

1746-0751

issn

1746-076X

journal_volume

1

pub_type

杂志文章
  • Muscle-derived stem cells in peripheral nerve regeneration: reality or illusion?

    abstract::Owing to the complicated and time-consuming regenerative process, the repair of injured peripheral nerves depends largely on ongoing stem-cell therapy. Decades ago, researchers successfully isolated and identified muscle-derived stem cells (MDSCs) and discovered their potential for multidifferentiation. MDSCs play an ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0165

    authors: Zhou J,Cui H,Lu H,Xu Z,Feng W,Chen L,Jin X,Yang X,Qi Z

    更新日期:2017-04-01 00:00:00

  • Culture conditions for primary human limbal epithelial cells.

    abstract::The cornea at the front of the eye is covered by an epithelium. This epithelium is maintained by stem cells located at the periphery of the cornea, in a region known as the limbus. Because this region harbors the stem cells for the corneal epithelium, the so-called limbal stem cells, its culture provides considerable ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.7

    authors: Osei-Bempong C,Henein C,Ahmad S

    更新日期:2009-05-01 00:00:00

  • Optimizing the safety of intradiscal platelet-rich plasma: an in vitro study with Cutibacterium acnes.

    abstract::Aim: The most common risk associated with intradiscal injection of platelet-rich plasma (PRP) is discitis with Cutibacterium acnes. It is hypothesized that antimicrobial activity of PRP can be enhanced through inclusion of leukocytes or antibiotics in the injectate. Materials & methods: Multiple PRP preparations of va...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0098

    authors: Prysak MH,Lutz CG,Zukofsky TA,Katz JM,Everts PA,Lutz GE

    更新日期:2019-10-01 00:00:00

  • Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study.

    abstract:AIM:This study presents an interim safety and feasibility analysis of the REGENERATE-IHD randomized controlled trial, which is examining the safety and efficacy of three different delivery routes of bone marrow-derived stem cells (BMSCs) in patients with ischemic heart failure. METHODS & RESULTS:The first 58 patients ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.2217/rme.14.3

    authors: Mozid A,Yeo C,Arnous S,Ako E,Saunders N,Locca D,Brookman P,Archbold RA,Rothman M,Mills P,Agrawal S,Martin J,Mathur A

    更新日期:2014-05-01 00:00:00

  • Reliable assessment of bone marrow and bone marrow concentrates using automated hematology analyzer.

    abstract::Aim: A limiting factor in advancement of bone marrow based cell therapies is the lack of characterization of cell products delivered to patients. Methods: Using an automated hematology analyzer that can be implemented in clinical setting, the composition of bone marrow aspirates (n = 17 patients) and bone marrow conce...

    journal_title:Regenerative medicine

    pub_type: 临床试验,杂志文章

    doi:10.2217/rme-2018-0173

    authors: Mantripragada VP,Piuzzi NS,George J,Bova W,Ng M,Boehm C,Muschler GF

    更新日期:2019-07-01 00:00:00

  • Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.

    abstract::Probably the most serious problem facing the field of regenerative medicine today is the challenge of effective translation and development of viable stem cell-based therapies. Particular concerns have been raised over the growing market in unproven cell therapies. In this article, I explore recent developments in the...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0065

    authors: Chan S

    更新日期:2017-10-01 00:00:00

  • The effects of polydeoxyribonucleotide on wound healing and tissue regeneration: a systematic review of the literature.

    abstract::Aim: The present study evaluated the effects of polydeoxyribonucleotide (PDRN) on tissue regeneration, paying special attention to the molecular mechanisms that underlie its tissue remodeling actions to better identify its effective therapeutic potential in wound healing. Materials & methods: Strategic searches were c...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0118

    authors: Colangelo MT,Galli C,Guizzardi S

    更新日期:2020-08-06 00:00:00

  • The regenerative therapies of the ankle degeneration: a focus on multipotential mesenchymal stromal cells.

    abstract::The ankle degeneration ranging from focal osteochondral lesions to osteoarthritis can cause a total joint function loss. With rising life expectancy and activity of the patients, various regenerative therapies were introduced aiming to preserve the joint function via the induction of cartilage and bone repair. Here, b...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0104

    authors: El-Jawhari JJ,Brockett CL,Ktistakis I,Jones E,Giannoudis PV

    更新日期:2018-03-19 00:00:00

  • Conference scene. A bright future for tissue engineering and regenerative medicine in the Asia Pacific region.

    abstract::The Tissue Engineering and Regenerative Medicine International Society-Asia Pacific (TERMIS-AP) annual meeting was held in Sydney, Australia from 15-17 September 2010 and highlighted the latest developments in tissue engineering and regenerative medicine in the Asia-Pacific region. Several of the plenary lectures focu...

    journal_title:Regenerative medicine

    pub_type:

    doi:10.2217/rme.11.7

    authors: Frith JE,Hudson JE,Cooper-White JJ

    更新日期:2011-03-01 00:00:00

  • Vascularization in 3D tissue using cell sheet technology.

    abstract::Tissue engineering is a field of study unto itself, but in reality, it is a fusion of medicine, pharmacology, chemistry, cell biology, molecular biology and engineering. The field has been developing at an ever-increasing pace and already provides benefits to regenerative medicine in areas such as the skin and cornea....

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.16

    authors: Sekiya S,Shimizu T,Okano T

    更新日期:2013-05-01 00:00:00

  • Restoration of cartilage defects using a superparamagnetic iron oxide-labeled adipose-derived mesenchymal stem cell and TGF-β3-loaded bilayer PLGA construct.

    abstract::Aim: We aimed to evaluate the capacity of the bilayer polylactic-co-glycolic acid (PLGA)/TGF-β3/adipose-derived mesenchymal stem cell (ADSC) construct used to repair cartilage defects and the role of ADSCs in the repair process in vivo. Materials & methods: Defects were created surgically on the femoropatellar groove ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0151

    authors: Yang ZG,Tang RF,Qi YY,Chen WP,Xiong Y,Wu LD

    更新日期:2020-06-01 00:00:00

  • Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.

    abstract::Human embryonic stem cells (ESCs) can be induced to differentiate into a wide range of tissues that soon could be used for therapeutic applications in regenerative medicine. Despite their developmental potential, sources used to generate human ESC lines raise serious ethical concerns, which recently prompted efforts t...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.09.46

    authors: Lee H,Park J,Forget BG,Gaines P

    更新日期:2009-09-01 00:00:00

  • Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.

    abstract::Parkinson's disease and Alzheimer's disease are the most common neurodegenerative diseases in the elderly population. Given that age is the most important risk factor in these diseases, the number of patients is expected to rise dramatically in the coming years. Therefore, an effective therapy for these diseases is hi...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.2.4.425

    authors: Korecka JA,Verhaagen J,Hol EM

    更新日期:2007-07-01 00:00:00

  • Recreating composition, structure, functionalities of tissues at nanoscale for regenerative medicine.

    abstract::Nanotechnology offers significant potential in regenerative medicine, specifically with the ability to mimic tissue architecture at the nanoscale. In this perspective, we highlight key achievements in the nanotechnology field for successfully mimicking the composition and structure of different tissues, and the develo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0120

    authors: Alarçin E,Guan X,Kashaf SS,Elbaradie K,Yang H,Jang HL,Khademhosseini A

    更新日期:2016-12-01 00:00:00

  • Enhancing medial layer recellularization of tissue-engineered blood vessels using radial microchannels.

    abstract::Aim: Cell repopulation of tissue-engineered vascular grafts (TEVGs) from decellularized arterial scaffolds is limited by dense concentric tunica media layers which impede cells migrating radially between the layers. We aimed to develop and validate a new microneedle device to modify decellularized carotid arteries wit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0011

    authors: Eufrásio-da-Silva T,Ruiz-Hernandez E,O'Dwyer J,Picazo-Frutos D,Duffy GP,Murphy BP

    更新日期:2019-11-01 00:00:00

  • Identity and ownership issues in the regulation of autologous cells.

    abstract::Clinical application of autologous cells by businesses promoting unproven stem cell treatments represents the largest growth sector in this problematic industry, but also presents special challenges to regulators. Patients frequently identify autologous cells as personal property, using the language of 'ownership'. Th...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0063

    authors: Sipp D

    更新日期:2017-10-01 00:00:00

  • Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.

    abstract:AIM:Dendritic cell (DC)-based vaccines have a potential utility for use in the treatment of malignancy. Human embryonic stem cells (hESCs) may provide a more cost-effective and reliable source of DCs for immunotherapy purposes, providing on-demand access for patients. METHOD:We developed a protocol to generate DCs fro...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.25

    authors: Tseng SY,Nishimoto KP,Silk KM,Majumdar AS,Dawes GN,Waldmann H,Fairchild PJ,Lebkowski JS,Reddy A

    更新日期:2009-07-01 00:00:00

  • Company profile: Sistemic Ltd.

    abstract::Founded in 2009 and headquartered in Glasgow, Scotland, UK, Sistemic Ltd has developed from a thought in the minds of four scientists into a company working globally to play its part in delivering the exciting opportunities for improvements in human health presented by cell therapies and regenerative medicine products...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.58

    authors: Reid J

    更新日期:2013-09-01 00:00:00

  • Prospects of stem cell therapy in osteoarthritis.

    abstract::Osteoarthritis is a common disorder in which there is not only extensive degeneration but also an aberrant attempt at repair in joints. Stem cell therapy could provide a permanent, biological solution, with all sources of stem cells (embryonic, fetal and adult) showing some degree of potential. Mesenchymal stromal/ste...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.11.21

    authors: Roberts S,Genever P,McCaskie A,De Bari C

    更新日期:2011-05-01 00:00:00

  • A xenobiotic-free culture system for human limbal epithelial stem cells.

    abstract:AIMS:Murine 3T3 feeder cells are commonly used for stem cell expansion. Although 'feeder-free' systems are being developed for a variety of stem cells including embryonic, the use of feeder cells currently remains optimal for the expansion of epithelial stem cells. In this study, MRC-5, a human embryonic fibroblast cel...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.6.919

    authors: Notara M,Haddow DB,MacNeil S,Daniels JT

    更新日期:2007-11-01 00:00:00

  • The role of policies and networks in development of cord blood usage in China.

    abstract::Research regarding the use of cord blood (CB) has focused on antigen match and the number of stem cells, with policies and networks related to its use being under researched. This article is based on fieldwork in China from 2013 to 2015 and examines ways that the studied CB bank enhances CB usage in China. This articl...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0050

    authors: Chang HC

    更新日期:2017-09-01 00:00:00

  • Safety and efficacy of cell therapies administered in the acute and subacute stages after stroke: a meta-analysis.

    abstract:AIMS:To evaluate the safety and efficacy of cell therapies administered acutely/sub-acutely after stroke. METHODS:Five databases were searched for studies examining the safety/efficacy of cell therapies administered ≤90 days post-stroke. Reporting quality and adherence to research guidelines were evaluated. Safety and...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,meta分析,评审

    doi:10.2217/rme-2016-0063

    authors: Unsworth DJ,Mathias JL,Dorstyn DS

    更新日期:2016-10-01 00:00:00

  • Functional motor recovery after peripheral nerve repair with an aligned nanofiber tubular conduit in a rat model.

    abstract:AIM:Current synthetic tubular conduits are inferior to nerve autograft for the repair of segmental peripheral nerve injuries. We examined motor outcomes with the use of longitudinally aligned poly (L-lactide-co-caprolactone) nanofiber conduits for repair of nerve gap injury in a rat model. METHODS:Ten-millimeter segme...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.12.87

    authors: Jin J,Park M,Rengarajan A,Zhang Q,Limburg S,Joshi SK,Patel S,Kim HT,Kuo AC

    更新日期:2012-11-01 00:00:00

  • Industry updates from the field of stem cell research and regenerative medicine in March 2020.

    abstract::Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions in March 2020. ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0052

    authors: Ilic D,Liovic M

    更新日期:2020-07-01 00:00:00

  • Biocompatibility and the efficacy of medical implants.

    abstract::Biocompatibility is key to the performance of any material in a biological environment. This review outlines current opinion on the factors that lead to biocompatibility and focuses on the interactions that occur at the interface between material and environment. The sequence of events, from protein adsorption, cell a...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.1.6.789

    authors: Shard AG,Tomlins PE

    更新日期:2006-11-01 00:00:00

  • Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

    abstract:AIM:To evaluate the in vitro immunogenic and immunomodulatory properties of induced pluripotent stem cells (iPSCs) compared with bone marrow-derived mesenchymal stromal cells (MSCs). MATERIALS & METHODS:Mouse embryonic fibroblasts (MEFs) were isolated from C3HeB/FeJ and C57BL/6J mice, and reprogrammed to generate iPSC...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.29

    authors: Schnabel LV,Abratte CM,Schimenti JC,Felippe MJ,Cassano JM,Southard TL,Cross JA,Fortier LA

    更新日期:2014-01-01 00:00:00

  • The UK Stem Cell Bank: a UK government-funded, international resource center for stem cell research.

    abstract::The UK Stem Cell Bank is a UK Research Council-funded initiative that aims to provide ethically sourced and quality controlled stocks of cells for researchers and also establish seed stocks of cell lines for clinical trials. Whilst the Bank is prohibited from carrying out basic stem cell research (to avoid conflicts o...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.1.1.139

    authors: Stacey G,Hunt CJ

    更新日期:2006-01-01 00:00:00

  • Hydrogen sulfide enhances pancreatic β-cell differentiation from human tooth under normal and glucotoxic conditions.

    abstract:AIM:Glucotoxicity obstructs pancreatic differentiation from adult stem cells. The aim was to develop a novel protocol for differentiation of dental pulp stem cells (DPSCs) into pancreatic β cells and determine the effect of H2S on glucotoxicity. MATERIALS & METHODS:DPSCs were differentiated with media containing 5.5 o...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2016-0142

    authors: Matei IV,Ii H,Yaegaki K

    更新日期:2017-03-01 00:00:00

  • Interview: Discussions on the development of human embryonic stem cell-based therapies.

    abstract::Dr Jane Lebkowski joined Geron Corporation in 1998 and is currently Senior Vice President and Chief Scientific Officer of the Regenerative Medicine Division. Dr Lebkowski heads Geron's human embryonic stem cell program, and is responsible for all research, preclinical development, product development, manufacturing an...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme.09.49

    authors: Lebkowski JS

    更新日期:2009-09-01 00:00:00

  • The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics.

    abstract:AIM:This paper aims to map the trends and analyze key institutional dynamics that constitute the policies for reimbursement of regenerative medicine (RM), especially in the UK. MATERIALS & METHODS:Two quantitative publications studies using Google Scholar and a qualitative study based on a larger study of 43 semi-stru...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0041

    authors: Mahalatchimy A,Faulkner A

    更新日期:2017-09-01 00:00:00